Recruiting
Phase 2

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Sponsor:

St. Joseph's Hospital and Medical Center, Phoenix

Code:

NCT04032626

Conditions

Cognitive Impairment, Mild

Cognitive Dysfunction

Amyloid Plaque

Neurodegeneration

Inflammation, Brain

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide 10 mg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information